BluHaven Health, P.A.

BluHaven Health, P. A. , based in the US, provides specialized infusion therapy services for patients with rare and complex diseases, focusing on comfort and personalized care in a supportive environment. Founded in 2015 and headquartered in Raleigh, North Carolina, BluHaven Health, P.

A. offers infusion therapy services tailored to individuals with chronic conditions. The firm has engaged in one deal to date, with its most recent deal recorded on June 2, 2026. The company operates independently without any known parent or subsidiary affiliations.

While specific details regarding the founder are not available, the company has maintained its core focus on patient-centered care since its inception. BluHaven Health specializes in providing infusion therapy services designed to cater to patients with rare, chronic, or complex diseases. Their core offerings include a range of infusion treatments for conditions such as rheumatoid arthritis, psoriatic arthritis, lupus, and various neurological disorders, including Alzheimer’s disease and Multiple Sclerosis. The center employs a team of experienced healthcare professionals who prioritize patient comfort and convenience, offering a spa-like experience with private and open infusion spaces.

This innovative approach allows patients to choose how they receive their treatment, whether in a quiet room for privacy or in a communal environment for social support. BluHaven Health serves a diverse clientele, including individuals seeking specialized care for autoimmune disorders and primary immunodeficiency diseases, with a particular focus on the Raleigh, North Carolina area while also catering to patients in surrounding regions. BluHaven Health generates revenue through direct patient services, primarily focusing on infusion therapy. The company operates on a direct-to-consumer model, where patients receive treatments that are covered by various insurance plans, often requiring prior authorization.

Each treatment session is billed based on the specific therapy administered, which includes both the administration of medications and the use of infusion resources. The structure of transactions typically involves insurance reimbursements, where patients may have co-pays or deductibles based on their individual plans. While specific pricing details for treatments are not disclosed, the company’s offerings are designed to meet the needs of patients requiring specialized care, ensuring that access to necessary therapeutic interventions is streamlined and efficient. BluHaven Health is strategically positioned for growth with plans to launch new infusion therapy products and expand its services into neighboring markets.

The company is targeting additional geographic regions to enhance patient access, supported by the resources from its recent deal on June 2, 2026, which has allowed for business development enhancements through the acquisition of Realo Specialty Care Pharmacy by Soleo Health Holdings, Inc. This acquisition is expected to bolster BluHaven's capabilities in meeting the needs of its clientele.